Strategy | Financing Transactions Private Placement / Financing Transactions Tune Therapeutics: The company raised $182.4 million of Series B venture funding in a deal led by Hevolution Foundation, Regeneron Ventures and Yosemite on January 23, 2025, putting the...
Strategy | Financing Transactions Private Placement / Financing Transactions Truveta: The company raised $320 million of Series C venture funding from Illumina and Regeneron Pharmaceuticals on January 13, 2025, putting the company’s pre-money valuation at $1.2...
Strategy | Financing Transactions Private Placement / Financing Transactions Verdiva Bio: The company raised $410 million of Series A venture funding in a deal led by General Atlantic and Forbion on January 9, 2025. Lilly Asia Ventures, OrbiMed, LYFE Capital, RA...
Strategy | Financing Transactions Private Placement / Financing Transactions Alzheon: The company raised $125 million of Series E venture funding in a deal led by Alerce Medical Technology Partners on January 2, 2025. The company is a developer of a small...
Strategy | Financing Transactions Private Placement / Financing Transactions Borealis Biosciences: The company raised $180 million of Series A venture funding in a deal led by Novartis and Westlake Village BioPartners on December 19, 2024. Versant Ventures and other...
Strategy | Financing Transactions Private Placement / Financing Transactions Angitia Biopharmaceuticals: The company raised $120 million of Series C venture funding in a deal led by Bain Capital Life Sciences on December 11, 2024. Yonghua Capital, 3H Health...
